Novo Nordisk, a global healthcare company, on Friday announced the launch of its once-weekly diabetes drug Ozempic® (injectable semaglutide) in India, marking a significant addition to the country’s ...
Many people are confused by normal fasting sugar readings alongside higher HbA1c lab results. This mismatch highlights hidden ...
A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured 7 in 10 type 2 diabetics.
The Brighterside of News on MSN
Sleep, diet, and blood sugar: Study finds new link between sleep and metabolic health
Chronic sleep deprivation is a growing public health issue that continues to have devastating effects on individuals’ lives.
Curious how elderberry supplements affects blood sugar and the immune system? Learn what current research shows—plus safety ...
16h
Ozempic is finally in India, but what should you really know before getting swept up in the hype?
Ozempic, a GLP-1 receptor agonist, has officially launched in India, offering a new treatment option for type 2 diabetes.
The GLP-1 receptor agonist is approved in India as an adjunct to diet and exercise for adults with type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback